Open Cabinet
DirectoryAll TradesCompaniesOverviewLate FilingsMethodologyAbout
Open Cabinet

Executive branch stock tracker

DirectoryAll TradesCompaniesOverviewDownloadMethodologyAbout

More government accountability tools

Capitol ReleasesPress releases from all 535 members of Congress, searchable and updated four times a day.
Delegation DecodedState-by-state congressional delegation tracking for votes, bills, committees and campaign money.

Data from the U.S. Office of Government Ethics. For informational and journalism purposes only. Not investment advice.

Built by Trevor Brown

Source codeReport a bugContactMIT License
← Back to company lookup

VRTX

Vertex Pharmaceuticals Incorporated

SEC registrant: VERTEX PHARMACEUTICALS INC / MA, CIK 875320. Common stock (inferred from the name, not yet reviewed). Issuer name and CIK from the SEC company list fetched 2026-09-05; the ticker match itself uses the exchange lists described on the methodology page.

Filed as: VERTEX PHARMACEUTICALS I; VERTEX PHARMACEUTICALS INC; Vertex Pharmaceuticals, Inc. (VRTX).

3officials
20trades
~$1.1Mtrade volume (est.)

Estimated transaction volume by official

Donald J. Trump$1.1MSean Duffy$8KArjun Mody$8K

All Trades

DateOfficialAs filedTypeAmountVerification
June 15, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS INC filingPurchase$1K-$15K
Checked

An OCR program and an AI model each read this row and agreed. A page check confirmed this row.

June 12, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS INC filingSale$1K-$15K
Checked

The PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row.

June 3, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS I filingPurchase$1K-$15K
Checked

An OCR program and an AI model each read this row and agreed. A page check confirmed this row.

May 22, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS I filingSale$15K-$50K
Checked

An OCR program and an AI model each read this row and agreed. A page check confirmed this row.

May 18, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS I filingSale$15K-$50K
Checked

An OCR program and an AI model each read this row and agreed. A page check confirmed this row.

May 18, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS I filingSale$1K-$15K
Checked

An OCR program and an AI model each read this row and agreed. A page check confirmed this row.

May 15, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS INC filingPurchase$1K-$15K
Checked

An OCR program and an AI model each read this row and agreed. A page check confirmed this row.

May 11, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS INC filingSale$1K-$15K
Checked

An OCR program and an AI model each read this row and agreed. A page check confirmed this row.

April 28, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS I filingSale$1K-$15K
Checked

An OCR program and an AI model each read this row and agreed. A page check confirmed this row.

April 27, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS INC filingSale$15K-$50K
Checked

An OCR program and an AI model each read this row and agreed. A page check confirmed this row.

April 17, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS I filingPurchase$1K-$15K
Checked

The PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row.

April 17, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS INC filingPurchase$500K-$1M
Checked

The PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row.

April 7, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS INC filingSale$1K-$15K
Checked

The PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row.

March 26, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS I filingPurchase$1K-$15K
Checked

The PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row.

March 17, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS I filingPurchase$1K-$15K
Checked

The PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row.

Feb. 19, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS INC filingPurchase$1K-$15K
Checked

The PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row.

Feb. 12, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS I filingPurchase$15K-$50K
Checked

The PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row.

Jan. 30, 2026Arjun Mody
Deputy Commissioner, Social Security Administration
Vertex Pharmaceuticals, Inc. (VRTX) filingSale$1K-$15K
Checked

The PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row.

Jan. 6, 2026Donald J. Trump
President of the United States
VERTEX PHARMACEUTICALS INC filingPurchase$50K-$100K
Checked

The PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row.

Feb. 11, 2025Sean Duffy
Secretary
Vertex Pharmaceuticals, Inc. (VRTX) filingSale$1K-$15K
Checked

A PDF parser and an AI model each read this filing and agreed on every row. A page check confirmed this row.

Source: U.S. Office of Government Ethics. Values reported in ranges per federal law. A trade is listed here only when its printed name was read the same way by two independent readers and matched this security exactly, by symbol or by name on two reference lists, or a person confirmed it. Broker abbreviations still under review are not listed; the trades stay on the official’s page under the printed name.